Disclosures for "Long-Term Efficacy of Perampanel Monotherapy in Patients with Newly Diagnosed/Currently Untreated Recurrent Focal-Onset Seizures: FREEDOM Study 342 Extension Phase Analysis by Seizure Type ")
-
Sung Chul Lim has nothing to disclose.
-
Anna Patten, 14934 has received personal compensation for serving as an employee of Eisai Ltd.
-
An immediate family member of Dr. Morita has received personal compensation for serving as an employee of Forrester Research. An immediate family member of Dr. Morita has received stock or an ownership interest from Forrester Research. The institution of Dr. Morita has received research support from Cleveland Clinic.
-
Dr. Ngo has received personal compensation for serving as an employee of Eisai Inc..
-
Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.